Sulfadiazine/Trimethoprim

磺胺嘧啶/甲氧苄啶

Report date: 2022/01/14 13:23:58

Base Information

Drug NameSulfadiazine/Trimethoprim
Drug Alias NameCompound Sulfadiazine Granules双嘧啶颗粒
ClassificationSmall molecules
Mechanisms of ActionDihydropteroate synthase inhibitorsDihydrofolate reductase inhibitors
TargetsDihydropteroate synthaseDihydrofolate reductase
Therapy Area/IndicationsOtitis MediaUrinary Tract InfectionsBronchitis, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes SulfadiazineTrimethoprim
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsOtitis MediaUrinary Tract InfectionsBronchitis, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A